A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by OncoMed Pharmaceuticals, Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Novotech (Australia) Pty Ltd
Information provided by (Responsible Party):
OncoMed Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01189942
First received: August 25, 2010
Last updated: December 15, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2013
  Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)